Titan Biotech (524717.BO) Stock Price

Titan Biotech Price

CLOSED
416.60INR-1.25 (-0.30 %)
Market closed

Over the last 13 years Titan Biotech grew revenue by 16.1% annually, reaching 1.56 B INR. Earnings per share have grown at 23.0% per year over the last 13 years. For Titan Biotech, the net margin of 13.8% is down versus 21.3% a few years ago. At today's price the dividend yield works out to roughly 0.48%. The payout ratio is around 8% of earnings. The dividend has grown at 22.0% per year over the past 13 years. The stock trades about 377% above its 52-week low.

Titan Biotech stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Titan Biotech over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Titan Biotech stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Titan Biotech's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Titan Biotech Stock Price History
DateTitan Biotech Price
8/3/2026416.60 INR
7/30/2026417.85 INR
7/29/2026419.15 INR
7/28/2026427.80 INR
7/27/2026414.90 INR
7/24/2026415.95 INR
7/23/2026423.75 INR
7/22/2026424.55 INR
7/21/2026428.70 INR
7/20/2026425.20 INR
7/17/2026424.85 INR
7/16/2026418.70 INR
7/15/2026407.15 INR
7/14/2026389.00 INR
7/13/2026400.30 INR
7/10/2026400.95 INR
7/9/2026390.70 INR
7/8/2026397.40 INR
7/7/2026396.75 INR
7/6/2026408.55 INR
7/3/2026389.10 INR
7/2/2026370.60 INR
7/1/2026371.70 INR
6/30/2026390.40 INR
6/29/2026397.90 INR
6/25/2026397.05 INR
6/24/2026413.05 INR
6/23/2026417.65 INR
6/22/2026429.15 INR
6/19/2026434.10 INR
6/18/2026428.45 INR
6/17/2026432.40 INR
6/16/2026442.60 INR
6/15/2026448.30 INR
6/12/2026444.75 INR
6/11/2026442.40 INR
6/10/2026441.60 INR
6/9/2026434.10 INR
6/8/2026434.85 INR
6/5/2026442.30 INR
6/4/2026442.25 INR
6/3/2026449.55 INR
6/2/2026457.80 INR
6/1/2026456.60 INR
5/29/2026441.25 INR
5/28/2026451.95 INR
5/27/2026451.95 INR
5/26/2026462.60 INR
5/25/2026472.55 INR
5/22/2026450.05 INR
5/21/2026428.65 INR
5/20/2026409.80 INR
5/19/2026419.10 INR
5/18/2026433.70 INR
5/15/2026452.90 INR
5/14/2026461.80 INR
5/13/2026460.75 INR
5/12/2026457.50 INR
5/11/2026462.20 INR
5/8/2026462.95 INR
5/7/2026465.65 INR
5/6/2026471.85 INR
5/5/2026484.70 INR
5/4/2026496.15 INR
4/30/2026496.00 INR
4/29/2026474.45 INR
4/28/2026452.60 INR
4/27/2026468.40 INR
4/24/2026481.70 INR
4/23/2026491.10 INR
4/22/2026493.30 INR
4/21/2026469.85 INR
4/20/2026469.40 INR
4/17/2026474.60 INR
4/16/2026452.00 INR
4/15/2026430.50 INR
4/13/2026410.00 INR
4/10/2026431.55 INR
4/9/2026454.25 INR
4/8/2026478.15 INR
4/7/2026503.30 INR
4/6/2026529.20 INR
4/2/2026504.00 INR
4/1/2026480.00 INR
3/30/2026457.70 INR
3/27/2026436.10 INR
3/25/2026415.85 INR
3/24/2026400.15 INR
3/23/2026387.40 INR
3/20/2026396.55 INR
3/19/2026391.10 INR
3/18/2026385.50 INR
3/17/2026367.45 INR
3/16/2026350.15 INR
3/13/2026368.55 INR
3/12/2026387.70 INR
3/11/2026369.50 INR
3/10/2026338.70 INR
3/9/2026297.80 INR
3/6/2026276.25 INR
3/5/2026256.95 INR
3/4/2026253.75 INR
3/2/2026220.20 INR
2/27/2026241.80 INR
2/26/2026247.50 INR
2/25/2026256.55 INR
2/24/2026262.85 INR
2/23/2026271.10 INR
2/20/2026297.75 INR
2/19/2026260.34 INR
2/18/2026258.94 INR
2/17/2026284.90 INR
2/16/2026260.47 INR
2/13/2026242.43 INR
2/12/2026227.58 INR
2/11/2026221.64 INR
2/10/2026206.45 INR
2/9/2026204.16 INR
2/6/2026202.84 INR
2/5/2026206.93 INR
2/4/2026201.76 INR
2/3/2026206.84 INR
2/2/2026200.02 INR
1/30/2026186.25 INR
1/29/2026190.07 INR
1/28/2026197.91 INR
1/27/2026195.37 INR
1/23/2026197.63 INR
1/22/2026195.93 INR
1/21/2026193.20 INR
1/20/2026198.45 INR
1/19/2026201.76 INR
1/16/2026204.05 INR
1/15/2026211.54 INR
1/14/2026211.54 INR
1/13/2026211.63 INR
1/12/2026206.72 INR
1/9/2026202.15 INR
1/8/2026207.68 INR
1/7/2026212.25 INR
1/6/2026214.65 INR
1/5/2026218.58 INR
1/2/2026216.29 INR
1/1/2026212.55 INR
12/31/2025210.76 INR
12/30/2025213.60 INR
12/29/2025210.48 INR
12/26/2025215.51 INR
12/24/2025220.31 INR
12/23/2025209.82 INR
12/22/2025211.33 INR
12/19/2025218.80 INR
12/18/2025216.49 INR
12/17/2025227.88 INR
12/16/2025239.87 INR
12/15/2025228.45 INR
12/12/2025217.58 INR
12/11/2025207.22 INR
12/10/2025198.71 INR
12/9/2025189.25 INR
12/8/2025180.32 INR
12/5/2025188.27 INR
12/4/2025194.32 INR
12/3/2025196.74 INR
12/2/2025196.39 INR
12/1/2025198.55 INR
11/28/2025195.90 INR
11/27/2025201.77 INR
11/26/2025204.17 INR
11/25/2025205.47 INR
11/24/2025195.82 INR
11/21/2025186.50 INR
11/20/2025190.30 INR
11/19/2025194.18 INR
11/18/2025198.14 INR
11/17/2025202.18 INR
11/14/2025198.22 INR
11/13/2025194.34 INR
11/12/2025190.53 INR
11/11/2025186.80 INR
11/10/2025190.61 INR
11/7/2025194.49 INR
11/6/2025198.45 INR
11/4/2025202.50 INR
11/3/2025206.63 INR
10/31/2025210.84 INR
10/30/2025215.14 INR
10/29/2025219.53 INR
10/28/2025224.01 INR
10/27/2025228.58 INR
10/24/2025233.24 INR
10/23/2025237.99 INR
10/21/2025247.79 INR
10/20/2025247.79 INR
10/17/2025252.84 INR
10/16/2025257.99 INR
10/15/2025271.56 INR
10/14/2025261.31 INR
10/13/2025248.97 INR
10/10/2025237.12 INR
10/9/2025226.19 INR
10/8/2025215.42 INR
10/7/2025205.17 INR
10/6/2025195.40 INR
10/3/2025193.76 INR
10/1/2025190.54 INR
9/30/2025189.66 INR
9/29/2025187.77 INR
9/26/2025180.47 INR
9/25/2025185.64 INR
9/24/2025194.71 INR
9/23/2025199.26 INR
9/22/2025196.07 INR
9/19/2025192.42 INR
9/18/2025185.50 INR
9/17/2025178.98 INR
9/16/2025170.46 INR
9/15/2025162.35 INR
9/12/2025156.14 INR
9/11/2025148.71 INR
9/10/2025141.63 INR
9/9/2025134.89 INR
9/8/2025133.27 INR
9/5/2025139.42 INR
9/4/2025136.89 INR
9/3/2025140.81 INR
9/2/2025136.03 INR
9/1/2025149.79 INR
8/29/2025144.70 INR
8/28/2025127.65 INR
8/26/2025109.37 INR
8/25/202593.37 INR
8/22/202589.19 INR
8/21/202590.82 INR
8/20/202591.79 INR
8/19/202591.37 INR
8/18/202592.52 INR
8/14/202594.22 INR
8/13/202588.16 INR
8/12/202587.37 INR
8/11/202588.33 INR
8/8/202588.47 INR
8/7/202592.80 INR
8/6/202594.46 INR
Access this data via the Eulerpool API
Get Free API Key

Titan Biotech Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
573.74 M INR
60.43 M INR
25.43 M INR
Jan 1, 2019
649.08 M INR
72.13 M INR
35.22 M INR
Jan 1, 2020
794.38 M INR
116.82 M INR
70.66 M INR
Jan 1, 2021
1.42 B INR
439.12 M INR
303.35 M INR
Jan 1, 2022
1.24 B INR
289.02 M INR
216.84 M INR
Jan 1, 2023
1.44 B INR
269.19 M INR
248.44 M INR
Jan 1, 2024
1.64 B INR
309.51 M INR
248.53 M INR
Jan 1, 2025
1.56 B INR
212.57 M INR
215.32 M INR

Titan Biotech Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 5, 2026, 1:39 PM
 
REVENUEB INR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM INR
EBITM INR
EBIT MARGIN%
NET INCOMEM INR
NET INCOME GROWTH%
DIV.INR
DIV. GROWTH%
SHARESM
20122013201420152016201720182019202020212022202320242025
0.230.270.390.400.460.530.570.650.791.421.241.441.641.56
–20.0044.813.0713.4015.328.7313.2622.3479.09-13.1516.5213.97-4.63
32.4434.8133.5037.2225.8226.9444.5049.6150.3854.5744.5342.1144.3944.57
73.0094.00131.00150.00118.00142.00255.00322.00400.00776.00550.00606.00728.00697.00
18.0022.0022.0030.0030.0045.0060.0072.00116.00439.00289.00269.00309.00212.00
8.008.155.637.446.568.5410.4711.0914.6130.8723.4018.6918.8413.55
12.0013.0014.0016.0017.0021.0025.0035.0070.00303.00216.00248.00248.00215.00
–8.337.6914.296.2523.5319.0540.00100.00332.86-28.7114.81–-13.31
0.150.750.750.750.750.750.750.151.001.501.501.802.002.00
–400.00–––––-80.00566.6750.00–20.0011.11–
35.1935.1935.1938.6938.6938.6938.6941.3241.3241.3241.3241.3241.3241.32
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Titan Biotech generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Titan Biotech retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Titan Biotech's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Titan Biotech has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Titan Biotech's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Titan Biotech stock margins

The Titan Biotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Titan Biotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Titan Biotech.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
44.62 %
10.53 %
4.43 %
Jan 1, 2019
49.62 %
11.11 %
5.43 %
Jan 1, 2020
50.47 %
14.71 %
8.89 %
Jan 1, 2021
54.61 %
30.87 %
21.33 %
Jan 1, 2022
44.53 %
23.39 %
17.55 %
Jan 1, 2023
42.11 %
18.69 %
17.25 %
Jan 1, 2024
44.42 %
18.86 %
15.15 %
Jan 1, 2025
44.58 %
13.59 %
13.76 %

Titan Biotech Stock Revenue, EBIT, Earnings per Share

The Titan Biotech earnings per share therefore indicates how much revenue Titan Biotech has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
2.97 INR
0.31 INR
0.13 INR
Jan 1, 2019
3.14 INR
0.35 INR
0.17 INR
Jan 1, 2020
3.85 INR
0.57 INR
0.34 INR
Jan 1, 2021
6.88 INR
2.13 INR
1.47 INR
Jan 1, 2022
5.98 INR
1.40 INR
1.05 INR
Jan 1, 2023
6.97 INR
1.30 INR
1.20 INR
Jan 1, 2024
7.94 INR
1.50 INR
1.20 INR
Jan 1, 2025
7.57 INR
1.03 INR
1.04 INR

Titan Biotech business model & stock analysis

Titan Biotech Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Titan Biotech historical P/E ratio, EBIT multiple, and P/S ratio

Titan Biotech annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Titan Biotech shares outstanding

The number of shares of Titan Biotech was 206.59 M in 2025. This indicates how many shares Titan Biotech is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
193.47 M Stocks
Jan 1, 2019
206.59 M Stocks
Jan 1, 2020
206.59 M Stocks
Jan 1, 2021
206.59 M Stocks
Jan 1, 2022
206.59 M Stocks
Jan 1, 2023
206.59 M Stocks
Jan 1, 2024
206.59 M Stocks
Jan 1, 2025
206.59 M Stocks

Titan Biotech stock splits

In Titan Biotech's history, there have been no stock splits.

Titan Biotech Dividend History

16 years of dividend payments

YearAnnual DividendYoY ChangePayments
20252.00INR 0.0%1×
Sep 19, 20252.00INR 0.0%1/1
20242.00INR↑ 11.1%1×
20231.80INR↑ 20.0%1×
20221.50INR 0.0%1×
20211.50INR↑ 50.0%1×
20201.00INR↑ 566.7%1×
20190.15INR↓ 80.0%—
20180.75INR 0.0%1×
20170.75INR 0.0%1×
20160.75INR 0.0%1×

Titan Biotech dividend history and estimates

In 2025, Titan Biotech paid a dividend amounting to 2.00 INR. Dividend means that Titan Biotech distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2018
0.75 INR
0.00 INR
Jan 1, 2019
0.15 INR
0.00 INR
Jan 1, 2020 (e)
0.00 INR
1.00 INR
Jan 1, 2021
1.50 INR
0.00 INR
Jan 1, 2022
1.50 INR
0.00 INR
Jan 1, 2023
1.80 INR
0.00 INR
Jan 1, 2024
2.00 INR
0.00 INR
Jan 1, 2025
2.00 INR
0.00 INR

Titan Biotech dividend payout ratio

In 2025, Titan Biotech had a payout ratio of 7.68%. The payout ratio indicates the percentage of the company's profits that Titan Biotech distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
23.08 %
Jan 1, 2019
6.77 %
Jan 1, 2020
11.70 %
Jan 1, 2021
4.09 %
Jan 1, 2022
5.73 %
Jan 1, 2023
5.99 %
Jan 1, 2024
6.65 %
Jan 1, 2025
7.68 %
Price targets and forecasts for Titan Biotech are not yet available.

Titan Biotech shareholder structure

% Name
33.59336%
Titan Securities Ltd
Titan Securities Ltd
9.63244%
Investor Education Protection Fund
Investor Education Protection Fund
9.49244%
Tanita Leasing & Finance, Ltd.
Tanita Leasing & Finance, Ltd.
6.77638%
Connoisseur Management Services Pvt. Ltd.
Connoisseur Management Services Pvt. Ltd.
2.80206%
Goel (Manish)
Goel (Manish)
1.27869%
Singla (Suresh Chand)
Singla (Suresh Chand)

Titan Biotech Executives and Management Board

14 members · avg. age 65 · 14 % women

NS

Mr. Naresh Singla (65)

Managing Director, Executive Director · since 2021

4.80 M INR

Management

SS

Mr. Suresh Singla

Managing Director, Executive Director · since 2021

4.00 M INR
PG

Mr. Prem Gupta

Chief Financial Officer

–
CS

Mr. Charanjit Singh

Compliance Officer, Company Secretary · since 2021

–
SS

Mr. Shivom Singla

Vice President - Bulk Division, Whole Time Director

–
US

Mr. Udit Singla

Vice President - Media Division, Whole Time Director

–

Board of Directors

RS

Mr. Raja Singla

Whole-Time Director · since 2019

–
MS

Mrs. Manju Singla

Non-Executive Director

–
SS

Ms. Supriya Singla

Non-Executive Director

–
AA

Mr. Abhishek Agarwal

Non-Executive Independent Director

–
RJ

Mr. Rohit Jain

Non-Executive Independent Director

–
DM

Mr. Dhairya Madan

Non-Executive Independent Director

–

Frequently asked questions about Titan Biotech

Converted at the current exchange rate, the Titan Biotech share trades at 3.79 EUR (416.60 INR).

No history available for Titan Biotech.

The revenue cannot currently be calculated for Titan Biotech.

The profit cannot currently be calculated for Titan Biotech.

The P/E ratio cannot be calculated for Titan Biotech at the moment.

The P/S cannot be calculated for Titan Biotech currently.

The Eulerpool Quality Score for Titan Biotech is 5/10.

The ISIN of Titan Biotech is INE150C01029. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Titan Biotech is 524717.BO. The ticker symbol is used to trade Titan Biotech shares on the stock exchange.

Over the past 12 months, Titan Biotech paid a dividend of 2.00 INR . This corresponds to a dividend yield of about 0.48 %. For the coming 12 months, Titan Biotech is expected to pay a dividend of 0.40 INR.

The current dividend yield of Titan Biotech is 0.48 %.

Titan Biotech pays a dividend, distributed in the months of , , , .

Titan Biotech paid dividends every year for the past 6 years.

For the upcoming 12 months, dividends amounting to 0.40 INR are expected. This corresponds to a dividend yield of 0.10 %.

Titan Biotech is assigned to the 'Commodities' sector.

To receive the latest dividend of Titan Biotech from amounting to 2 INR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Titan Biotech distributed 0.36 INR as dividends.

The dividends of Titan Biotech are distributed in INR.

All fundamentals and in-depth analysis of Titan Biotech

Our stock analysis for Titan Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Titan Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Titan Biotech Stock
Titan Biotech Revenue→
Titan Biotech Stock
Titan Biotech Net Income→
Titan Biotech Stock
Titan Biotech P/E→
Titan Biotech Stock
Titan Biotech P/S→
Titan Biotech Stock
Titan Biotech EBIT→
Titan Biotech Stock
Titan Biotech Dividend→
Titan Biotech Stock
Titan Biotech Directors Dealings→
Titan Biotech Stock
Titan Biotech Stocks→
Titan Biotech Stock
Titan Biotech Market capitalization→
Titan Biotech Stock
Titan Biotech Debt→
Titan Biotech Stock
Titan Biotech Liabilities→
Titan Biotech Stock
Titan Biotech Equity→
Titan Biotech Stock
Titan Biotech AAQS→
Titan Biotech Stock
Titan Biotech Employees→
Titan Biotech Stock
Titan Biotech ROE→
Titan Biotech Stock
Titan Biotech ROA→
Titan Biotech Stock
Titan Biotech ROCE→
Titan Biotech Stock
Titan Biotech News→
Titan Biotech Stock
Titan Biotech Analyst Price Targets→

Commodities Stocks

Titan KogyoTitanTitanium SandsTirupati Starch & ChemicalsTitomicTirupati GraphiteTivanTirta Mahakam Resources Tbk PTTKG Huchems CoTIPCO Asphalt PCLTMC the metals companyTintina MinesAll Stocks A–Z →